Clinical Trials Browser

Phase 2 × OTHER × IDO-1 inhibitor LY3381916 × Clear all

NCT01822691 2016-01-18

Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

Phase 2 Completed

15 enrolled 8 charts

Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute